Media headlines about Simulations Plus (NASDAQ:SLP) have trended positive recently, Alpha One Sentiment Analysis reports. The research group, a unit of Accern, rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Alpha One ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Simulations Plus earned a news impact score of 0.47 on Alpha One’s scale. Alpha One also gave news headlines about the technology company an impact score of 94 out of 100, meaning that recent media coverage is extremely likely to have an impact on the company’s share price in the near term.

These are some of the headlines that may have effected AlphaOne Sentiment’s scoring:

Shares of Simulations Plus (NASDAQ:SLP) traded up 1.32% during mid-day trading on Friday, hitting $11.55. 39,257 shares of the stock were exchanged. The company has a market capitalization of $199.12 million, a PE ratio of 37.75 and a beta of -0.17. The firm has a 50-day moving average price of $10.74 and a 200 day moving average price of $9.72. Simulations Plus has a 12-month low of $6.74 and a 12-month high of $11.75.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Monday, April 10th. The technology company reported $0.07 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by $0.01. Simulations Plus had a return on equity of 23.69% and a net margin of 25.33%. The firm had revenue of $5.71 million for the quarter, compared to analyst estimates of $5.54 million. On average, equities research analysts expect that Simulations Plus will post $0.32 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Positive News Coverage Extremely Likely to Impact Simulations Plus (SLP) Stock Price” was first published by Financial Market News and is owned by of Financial Market News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at

Simulations Plus Company Profile

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

5 Day Chart for NASDAQ:SLP

Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with's FREE daily email newsletter.